Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.

[1]  Nick Freemantle,et al.  Long‐term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE‐HF trial , 2009, European journal of heart failure.

[2]  J. Cleland,et al.  The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction , 2008, European journal of heart failure.

[3]  J. Cleland,et al.  The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure , 2007, European journal of heart failure.

[4]  J. Cleland,et al.  Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure , 2007, European journal of heart failure.

[5]  Nick Freemantle,et al.  Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. , 2007, European heart journal.

[6]  J. Daubert,et al.  Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. , 2006, European heart journal.

[7]  Nick Freemantle,et al.  Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge , 2007, European journal of heart failure.

[8]  J. Kautzner,et al.  Decrease in plasma B‐type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months , 2006, European journal of heart failure.

[9]  N. Freemantle,et al.  Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study). , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[10]  A. Rigby,et al.  Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. , 2006, The American journal of cardiology.

[11]  Nick Freemantle,et al.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. , 2006, European heart journal.

[12]  A. DeMaria,et al.  Dynamic ventricular dyssynchrony: an exercise-echocardiography study. , 2006, Journal of the American College of Cardiology.

[13]  N. Freemantle,et al.  Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction — a systematic review and meta‐analysis , 2006, European journal of heart failure.

[14]  Jeroen J. Bax,et al.  Effect of Posterolateral Scar Tissue on Clinical and Echocardiographic Improvement After Cardiac Resynchronization Therapy , 2006, Circulation.

[15]  J. Daubert,et al.  Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. , 2005, Journal of the American College of Cardiology.

[16]  G. Marcus,et al.  Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. , 2005, Journal of the American College of Cardiology.

[17]  D. Lake,et al.  Extent of myocardial viability predicts response to biventricular pacing in ischemic cardiomyopathy. , 2005, Heart rhythm.

[18]  Jeroen J. Bax,et al.  Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization Therapy , 2005, Circulation.

[19]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[20]  Christophe Leclercq,et al.  Predictors of response to cardiac resynchronization therapy (PROSPECT)--study design. , 2005, American heart journal.

[21]  J. Daubert,et al.  Baseline characteristics of patients recruited into the CARE‐HF study , 2005, European journal of heart failure.

[22]  S. Bolling,et al.  Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. , 2005, Journal of the American College of Cardiology.

[23]  Jeroen J. Bax,et al.  Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. , 2004, Journal of the American College of Cardiology.

[24]  Jeroen J. Bax,et al.  Echocardiographic evaluation of cardiac resynchronization therapy: Ready for routine clinical use? , 2004 .

[25]  Christophe Leclercq,et al.  Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. , 2004, Journal of the American College of Cardiology.

[26]  Yan Zhang,et al.  Tissue Doppler Imaging Is Superior to Strain Rate Imaging and Postsystolic Shortening on the Prediction of Reverse Remodeling in Both Ischemic and Nonischemic Heart Failure After Cardiac Resynchronization Therapy , 2004, Circulation.

[27]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[28]  Pedro Brugada,et al.  Improvement of Left Ventricular Function After Cardiac Resynchronization Therapy Is Predicted by Tissue Doppler Imaging Echocardiography , 2004, Circulation.

[29]  Jeroen J. Bax,et al.  Atrial and brain natriuretic peptides as markers of response to resynchronisation therapy , 2003, Heart.

[30]  N Freemantle,et al.  The CARE‐HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end‐points , 2001, European journal of heart failure.

[31]  J. Cleland,et al.  The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS) , 1999, European journal of heart failure.

[32]  M. Komajda,et al.  Risk stratification in chronic heart failure. , 1998, European heart journal.